Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis

被引:172
作者
Robinson, M
Regnis, JA
Bailey, DL
King, M
Bautovich, GJ
Bye, PT
机构
[1] ROYAL PRINCE ALFRED HOSP,RESP INVEST UNIT,CAMPERDOWN,NSW 2050,AUSTRALIA
[2] ROYAL PRINCE ALFRED HOSP,DEPT NUCL MED,SYDNEY,NSW,AUSTRALIA
[3] UNIV ALBERTA,PULM & CELL BIOL RES GRP,EDMONTON,AB,CANADA
关键词
D O I
10.1164/ajrccm.153.5.8630593
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In patients with cystic fibrosis (CF), dehydration of airway secretions leads to a decrease in mucociliary clearance (MCC). We examined the acute effect on MCC of a single administration by aerosolization of hypertonic saline (7%) (HS), amiloride (0.3% in 0.12% NaCl) (AML) and a combination of AML and HS (AM L + HS) in 12 patients with CF using a radioaerosol technique. Isotonic saline [0.9%] (IS) was used as a control solution. As both the AML and HS solutions induced cough in some patients, the last nine patients studied also underwent a cough clearance day. This was to eliminate the possible confounding effect of cough on MCC measurement. Patients ranged from 18 to 28 yr (mean +/- SD, 22 +/- 3) with an FEV(1) of 27 to 112% predicted (61 +/- 30%). Following deposition of the radioaerosol, baseline clearance was assessed for 30 min. This was followed by a 30-min intervention period. Assessment of post-intervention clearance for a further 30 min was then performed. Comparison of the amount of radioaerosol cleared from the right lung was made at 60 min (%C60) and 90 min (%C90) using repeated measures ANOVA. The percent cleared at 60 and 90 min was significantly increased with HS (%C60 = 26.5%, %C90 = 29.4%) and the combination of AML + HS (%C60 = 23.1%, %C90 = 27.4%) compared with both IS (%C60 = 14.7%, %C90 = 17.5%) and COUGH (%C60 = 18.0%, %C90 = 19.5%), p < 0.01. Inhalation of hypertonic saline is a potentially useful treatment in patients with cystic fibrosis.
引用
收藏
页码:1503 / 1509
页数:7
相关论文
共 33 条
[21]   APPARATUS FOR THE CONTROL OF BREATHING PATTERNS DURING AEROSOL INHALATION [J].
PHIPPS, PR ;
GONDA, I ;
ANDERSON, SD .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1992, 5 (03) :155-170
[22]  
POTTER JL, 1967, AM REV RESPIR DIS, V96, P83
[23]   MUCOCILIARY CLEARANCE IN PATIENTS WITH CYSTIC-FIBROSIS AND IN NORMAL SUBJECTS [J].
REGNIS, JA ;
ROBINSON, M ;
BAILEY, DL ;
COOK, P ;
HOOPER, P ;
CHAN, HK ;
GONDA, I ;
BAUTOVICH, G ;
BYE, PTP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (01) :66-71
[24]   NEDOCROMIL SODIUM INHIBITS THE AIRWAY RESPONSE TO HYPEROSMOLAR CHALLENGE IN PATIENTS WITH ASTHMA [J].
RODWELL, LT ;
ANDERSON, SD ;
DUTOIT, J ;
SEALE, JP .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (05) :1149-1155
[25]  
RODWELL LT, 1994, AUST NZ J MED, P484
[26]  
SCHEFFNER AL, 1964, AM REV RESPIR DIS, V90, P721
[27]   BRONCHIAL HYPERREACTIVITY IN RESPONSE TO INHALATION OF ULTRASONICALLY NEBULIZED SOLUTIONS OF DISTILLED WATER AND SALINE [J].
SCHOEFFEL, RE ;
ANDERSON, SD ;
ALTOUNYAN, REC .
BRITISH MEDICAL JOURNAL, 1981, 283 (6302) :1285-1287
[28]   EVIDENCE OF HYDROPHOBIC DOMAINS IN HUMAN RESPIRATORY MUCINS - EFFECT OF SODIUM-CHLORIDE ON HYDROPHOBIC BINDING-PROPERTIES [J].
SHANKAR, V ;
NAZIRUDDIN, B ;
DELAROCHA, SR ;
SACHDEV, GP .
BIOCHEMISTRY, 1990, 29 (24) :5856-5864
[29]   COMPLEX STRUCTURE OF HUMAN BRONCHIAL MUCUS GLYCOPROTEIN [J].
SLAYTER, HS ;
LAMBLIN, G ;
LETREUT, A ;
GALABERT, C ;
HOUDRET, N ;
DEGAND, P ;
ROUSSEL, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 142 (02) :209-218
[30]   AMILORIDE INHALATION-THERAPY IN CYSTIC-FIBROSIS - INFLUENCE ON ION CONTENT, HYDRATION, AND RHEOLOGY OF SPUTUM [J].
TOMKIEWICZ, RP ;
APP, EM ;
ZAYAS, JG ;
RAMIREZ, O ;
CHURCH, N ;
BOUCHER, RC ;
KNOWLES, MR ;
KING, M .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04) :1002-1007